SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Jon Koplik who wrote (2489)8/26/2001 1:11:52 PM
From: scotty  Read Replies (1) | Respond to of 3576
 
Jon, thanks for the article. Looks like Wall Street is skeptical. They'll see the light soon, maybe Monday...ggg.. One day the herd will want a piece of GERN, and the ramp will be breathtaking. The ramp may have started last week....."It's the most valuable patent estate in all of biotechnology"....I agree....scotty



To: Jon Koplik who wrote (2489)8/26/2001 9:21:15 PM
From: Savant  Respond to of 3576
 
Jon, I would be in favor of replacing Dr. Okarma with a professional media & investment intermediary. Let him do that which he does best, let someone else handle the press and stock people, someone that is less 'prickly' and 'offensive'..you know, slick and oily, like most successful CEOs.
Best, Savant


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News